Veroscience
VeroScience is a biotechnology company focused on developing therapies and products to improve human health, with a strong pipeline in metabolic diseases and immunological disorders.
Last updated September 1, 2026
Overview
VeroScience is a biotechnology company focused on the development of therapies and products to improve human health. The company has a strong pipeline of metabolic disease products and therapies for immunological disorders. VeroScience is a hybrid of academic environment mindset and industrial focus within a small and efficient organization. The company conducts preclinical and clinical research nation-wide, utilizing strong academic and pharmaceutical industry collaborations to advance its development programs. VeroScience is committed to developing novel, practical, and effective therapies for chronic debilitating human diseases such as Type 2 diabetes, metabolic syndrome, autoimmune disease, and cancer through interdisciplinary basic research. The company's approach focuses on readjusting aberrant central nervous system (CNS) modulation of neuroendocrine activities etiologic in or supportive of these disease states. VeroScience researchers study biological clocks within the central nervous system in vertebrates and their organizational influence on neuroendocrine regulation of physiology to develop new treatment strategies for metabolic and immune disorders. The company's main office is located in Tiverton, RI.
History
VeroScience is a biotechnology company focused on the development of therapies and products to improve human health. The company has a strong pipeline of metabolic disease products and therapies for immunological disorders. VeroScience is a hybrid of academic environment mindset and industrial focus within a small and efficient organization. The company conducts preclinical and clinical research nation-wide, utilizing strong academic and pharmaceutical industry collaborations to advance its development programs. VeroScience is committed to developing novel, practical, and effective therapies for chronic debilitating human diseases such as Type 2 diabetes, metabolic syndrome, autoimmune disease, and cancer through interdisciplinary basic research. The company's approach focuses on readjusting aberrant central nervous system (CNS) modulation of neuroendocrine activities etiologic in or supportive of these disease states. VeroScience researchers study biological clocks within the central nervous system in vertebrates and their organizational influence on neuroendocrine regulation of physiology to develop new treatment strategies for metabolic and immune disorders. The company's main office is located in Tiverton, RI.
Sources
Cite this profile: Cite the canonical profile. /brand-wiki/veroscience · Editorial policy · How profiles are compiled